09/25/2020 /
In this review, the authors discuss the current knowledge on sex differences in epilepsy and associated co-existing disorders, with emphasis on those aspects most informative for the development of new drug treatments.
09/25/2020 /
Health related quality of life (HRQoL) has become a pivotal outcome parameter after surgery for drug-resistant epilepsy. The aim of the study was to investigate HRQoL and its relationship to seizure outcome, neurological deficits, and anxiety after epilepsy surgery in a specific subpopulation of elderly patients.
09/24/2020 /
The objective of the study was to describe the cognitive, behavioral, psychological, and social functioning of individuals with Dravet syndrome. Click here to read the full abstract.
09/24/2020 /
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy when anti-seizure medications don’t work, according to a study published in the journal Neurology. Read more.
09/23/2020 /
The COVID-19 pandemic has affected people globally, and those with chronic diseases are suffering more in maintaining their mental and physical health. Researchers performed a cross-sectional, case-control study to assess the anxiety level in people with epilepsy compared with the general population.
09/23/2020 /
As concerns regarding neurological manifestations in COVID-19 patients increase, limited data exists on continuous electroencephalography (cEEG) findings in these patients. This article presents a retrospective cohort study of cEEG monitoring in COVID-19 patients to better explore this knowledge gap.
09/21/2020 /
Reports indicate that an early neurological manifestation with seizures should not be ruled out.
09/21/2020 /
Using an arithmetic technique to select the best combination two medications with the highest efficacy, researchers state that there is a positive interaction between two neurosteroids brexanolone and ganaxolone and two antiepileptic medications tiagabine and midazolam.
09/20/2020 /
The 3 papers included in this collection are peer-reviewed studies that systematically assessed EEGs in patients with COVID-19, as of July 26, 2020.
